Literature DB >> 6643764

Cutaneous complications of chemotherapeutic agents.

A K Bronner, A F Hood.   

Abstract

Increasing numbers of chemotherapeutic agents are being used to treat patients with cancer and various immunologically mediated and inflammatory disorders. Many of the drugs used have distinctive cutaneous side effects that range from relatively common ones, such as alopecia, stomatitis, and hyperpigmentation, to more unusual ones, such as radiation enhancement and recall phenomena, photosensitivity and hypersensitivity reactions, and phlebitis or chemical cellulitis. In addition, there are some rare complications such as diffuse sclerosis of the hands and feet, Raynaud's phenomenon, sterile folliculitis, and flushing reactions. By being aware of which drug may have caused a particular cutaneous reaction, dermatologists will be able to contribute to the care of patients with complex problems in a meaningful way.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6643764     DOI: 10.1016/s0190-9622(83)70177-5

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  11 in total

Review 1.  [Skin changes with chemotherapy].

Authors:  A L Branzan; M Landthaler; R-M Szeimies
Journal:  Hautarzt       Date:  2005-06       Impact factor: 0.751

2.  Cutaneous manifestations of Taxol therapy.

Authors:  C J Link; G A Sarosy; E C Kohn; M C Christian; P Davis; D O Adamo; E Reed
Journal:  Invest New Drugs       Date:  1995       Impact factor: 3.850

3.  Chemotherapy-induced palmar-plantar erythrodysesthesia syndrome--recall following different chemotherapy agents.

Authors:  Yuk Fung Hui; Francis J Giles; Jorge E Cortes
Journal:  Invest New Drugs       Date:  2002-02       Impact factor: 3.850

Review 4.  Mitigating acute chemotherapy-associated adverse events in patients with cancer.

Authors:  Nicole M Kuderer; Aakash Desai; Maryam B Lustberg; Gary H Lyman
Journal:  Nat Rev Clin Oncol       Date:  2022-10-11       Impact factor: 65.011

5.  Topical dimethylsulfoxide may prevent tissue damage from anthracycline extravasation.

Authors:  H J Lawrence; D Walsh; K A Zapotowski; A Denham; S H Goodnight; D R Gandara
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

6.  Bleomycin-induced flagellate dermatitis.

Authors:  Rachel Grynszpan; João Paulo Niemeyer-Corbellini; Marien Siqueira Soto Lopes; Marcia Ramos-e-Silva
Journal:  BMJ Case Rep       Date:  2013-06-27

Review 7.  Radiation recall with anticancer agents.

Authors:  Howard A Burris; Jane Hurtig
Journal:  Oncologist       Date:  2010-11-02

8.  Docetaxel extravasation results in significantly delayed and relapsed skin injury: A case report.

Authors:  Pei-Hung Chang; Mei-Ti Wang; Yi-Hua Chen; Yu-Ying Chen; Cheng-Hsu Wang
Journal:  Oncol Lett       Date:  2014-02-27       Impact factor: 2.967

9.  Radiation recall dermatitis after treatment with Paclitaxel and Cisplatin.

Authors:  Seung Woo Baek; Young Joon Seo; Jun Sang Kim; Hyo Jin Lee
Journal:  Ann Dermatol       Date:  2012-04-26       Impact factor: 1.444

Review 10.  Restorative oncodermatology: Diagnosis and management of dermatologic sequelae from cancer therapies.

Authors:  Anthony M Rossi; Brian P Hibler; Cristian Navarrete-Dechent; Mario E Lacouture
Journal:  J Am Acad Dermatol       Date:  2020-08-08       Impact factor: 15.487

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.